CO-DIAGNOSTIC ($CODX) posted quarterly earnings results for Q1 2026 on Thursday, May 14th. The company reported earnings of -$4.06 per share, missing estimates of -$3.83 by $0.23. The company also reported revenue of $150,000, missing estimates of $166,770 by $-16,770.
Stock price change since market close: -6.88%
You can see Quiver Quantitative's $CODX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CO-DIAGNOSTIC Hedge Fund Activity
We have seen 11 institutional investors add shares of CO-DIAGNOSTIC stock to their portfolio, and 22 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 14,248 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $26,501
- TOWER RESEARCH CAPITAL LLC (TRC) added 12,988 shares (+25976.0%) to their portfolio in Q4 2025, for an estimated $65,693
- JANE STREET GROUP, LLC removed 8,031 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $14,937
- VANGUARD GROUP INC added 6,772 shares (+11.9%) to their portfolio in Q4 2025, for an estimated $34,252
- UBS GROUP AG added 6,320 shares (+603.1%) to their portfolio in Q1 2026, for an estimated $11,755
- HRT FINANCIAL LP removed 4,976 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $25,168
- RENAISSANCE TECHNOLOGIES LLC removed 4,573 shares (-15.8%) from their portfolio in Q4 2025, for an estimated $23,130
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
